Central Pacific Bank Trust Division Purchases 76 Shares of STERIS plc (NYSE:STE)

Central Pacific Bank Trust Division increased its position in STERIS plc (NYSE:STE) by 65.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 192 shares of the medical equipment provider’s stock after acquiring an additional 76 shares during the quarter. Central Pacific Bank Trust Division’s holdings in STERIS were worth $39,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Bleakley Financial Group LLC increased its stake in shares of STERIS by 8.7% in the third quarter. Bleakley Financial Group LLC now owns 1,680 shares of the medical equipment provider’s stock worth $407,000 after purchasing an additional 134 shares during the period. Franklin Resources Inc. lifted its holdings in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after buying an additional 529,308 shares during the last quarter. Assetmark Inc. boosted its position in shares of STERIS by 24.6% in the third quarter. Assetmark Inc. now owns 13,410 shares of the medical equipment provider’s stock valued at $3,252,000 after acquiring an additional 2,647 shares during the period. KBC Group NV grew its stake in shares of STERIS by 52.0% in the third quarter. KBC Group NV now owns 12,071 shares of the medical equipment provider’s stock worth $2,928,000 after acquiring an additional 4,132 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in STERIS during the third quarter worth $9,949,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on STE shares. Stephens reissued an “overweight” rating and issued a $260.00 price target on shares of STERIS in a report on Thursday, November 7th. Piper Sandler raised STERIS from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $230.00 to $260.00 in a research report on Thursday, October 24th. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Monday, November 18th. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Finally, Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $262.50.

STERIS Trading Up 0.8 %

STE stock opened at $204.12 on Monday. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average is $215.22 and its 200-day moving average is $225.47. The firm has a market cap of $20.15 billion, a P/E ratio of 46.60 and a beta of 0.83.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $2.12 by $0.02. The firm had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.33 billion. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The business’s revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the business posted $2.03 earnings per share. Equities analysts anticipate that STERIS plc will post 9.1 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Tuesday, November 19th were paid a dividend of $0.57 per share. The ex-dividend date was Tuesday, November 19th. This represents a $2.28 annualized dividend and a yield of 1.12%. STERIS’s dividend payout ratio is 52.05%.

Insider Transactions at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the business’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the transaction, the senior vice president now owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. The trade was a 12.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.14% of the company’s stock.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.